87
likes
4
comments
daily view 0
monthly view 0
Live Analytics
Comments 0
Ozempic Is Rewiring the Economy. Here’s Who Wins and Loses. Analytics Table
Income Estimates for Ozempic Is Rewiring the Economy. Here’s Who Wins and Loses.
Based on this YouTube video's total view count of 52.8K views and industry-standard rates, the estimated total earning is $37 - $106 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About Ozempic Is Rewiring the Economy. Here’s Who Wins and Loses.
Explore Ozempic Is Rewiring the Economy. Here’s Who Wins and Loses. with 52,814 views, 87 likes, and 4 comments. Experience the impact of this video content that has captured audience attention.
21% of US households now have someone on a GLP-1. PwC’s Ali Furman on how Ozempic and other GLP-1s are rewiring the consumer economy. For 50 years the consumer economy was built on more: more calories, more volume, more impulse. GLP-1s are creating a consumer who wants less. David Rogier sits down with Ali Furman, who leads consumer markets research at PwC, and Sheila Kahyaoglu, aerospace and airline analyst at Jefferies, to follow the money through every industry the drugs are touching. Subscribe for a new episode every week: https://www.youtube.com/@masterclass/podcasts Listen on Apple Podcasts: https://podcasts.apple.com/bs/podcast/other-peoples-business/id6819444635 Listen on Spotify: https://open.spotify.com/show/4VKsvHx8C5IZdsTyWpGtWt?si=e842f16573284c20&nd=1&dlsi=e10b211f13284dd2 CHAPTERS 0:00 Cold open 0:39 Welcome: the drug that’s changing the economy 1:57 75% of US adults are overweight 2:59 From 9% to 21% of households in 12 months 3:51 What a GLP-1 actually does: food noise and 40% fewer calories 4:42 The end of “more” 5:36 Apparel: the biggest winner (occasion wear, tailoring, jewelry) 7:56 Happier, more confident, and maybe more divorced 9:04 Should plus-size brands panic? 10:16 Who’s really on it: income, ethnicity, Gen X, and a 50/50 gender split 12:00 The annual physical scenario: half the population in a decade 12:38 Do people keep the weight off? 14:51 The cons: what we don’t know yet 16:47 Grocery: jerky, Greek yogurt, and the shrinking basket 18:31 Why gum and mints are growing 19:30 Is Chipotle scared? What restaurants are getting wrong 22:19 Alcohol: double-digit declines in wine and spirits 23:46 Travel: from Vegas and Napa to hiking and spas 25:48 Sheila Kahyaoglu on airlines 27:29 The one-ounce magazine that saved 170,000 gallons 29:31 The 737 math: 10% lighter passengers, 1.5% less fuel 30:52 Billions in savings, and why it’s not hitting the bottom line 33:53 The tailwind that’s 12% of the population 35:38 Gyms, strength training, and the William Blair number 36:46 Beauty: Botox, filler, hair loss, and skin elasticity 38:25 Will skinny become mandatory? 39:39 Why people quit: side effects and cost 40:52 60% of consumers now research with AI, in 30-word prompts 42:29 What Ali would tell a family member 43:25 Would David take one? 45:22 David’s takeaways Class on GLP-1s and Weight Loss on MasterClass: https://www.masterclass.com/classes/understanding-glp-1s-and-weight-loss MORE FROM THE EPISODE Ali Furman, PwC: https://www.linkedin.com/in/ali-furman-643b641/ Ali Furman, PwC: https://www.instagram.com/alisonfurman_/ Sheila Kahyaoglu, Jefferies: https://www.linkedin.com/in/sheilakahyaoglu MORE FROM OTHER PEOPLE'S BUSINESS Hosted by David Rogier, Founder and CEO of MasterClass Instagram: https://www.instagram.com/masterclass/ LinkedIn: https://www.linkedin.com/company/masterclassinc David’s LinkedIn: https://www.linkedin.com/in/drogier/ David’s Instagram: https://www.instagram.com/davidjrogier/ About MasterClass: MasterClass is the streaming platform where anyone can learn from the world’s best. With an annual membership, subscribers get unlimited access to instructors and classes across a wide range of subjects. Stream thousands of lessons anywhere, anytime, on mobile, desktop, and TV. In this episode of Other People’s Business, David Rogier, the Founder and CEO of MasterClass, interviews Ali Furman of PwC and Sheila Kahyaoglu of Jefferies about the economy of GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Topics include how GLP-1 adoption is affecting consumer spending on groceries, restaurants, alcohol, apparel, travel, gyms, and beauty; who is using weight loss drugs across income, gender, and generation; what restaurants like Chipotle are changing; why airlines are saving on jet fuel costs because passengers weigh less; the wellness economy; and how consumers use AI to research health decisions. This episode is for informational purposes only and is not medical advice. • Subscribe: https://mstr.cl/30SH1wj • TikTok: https://www.tiktok.com/@masterclass • Instagram: https://www.instagram.com/masterclass • Twitter: https://www.twitter.com/masterclass • Facebook: https://www.facebook.com/masterclassofficial #MasterClass
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

